Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 134 | 123 | −11 |
| Shares | 65.9M | 70.5M | +4.63M (+7.0%) |
| Value | $248.0M | $300.5M | +$52.5M (+21.2%) |
New holders (18)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 3,022,784 | $12.9M | 0.01% |
| Birchview Capital, LP | 134,000 | $570.8K | 0.57% |
| XTX Topco Ltd | 80,414 | $342.6K | 0.01% |
| Thrivent Financial for Lutherans | 72,455 | $308.0K | 0.00% |
| ExodusPoint Capital Management, LP | 58,980 | $251.0K | 0.00% |
| State of Wisconsin Investment Board | 54,177 | $230.8K | 0.00% |
| Bridgeway Capital Management, LLC | 50,000 | $213.0K | 0.01% |
| Prelude Capital Management, LLC | 22,133 | $94.3K | 0.01% |
| Creative Planning | 19,521 | $83.2K | 0.00% |
| Titleist Asset Management, LLC | 15,000 | $63.9K | 0.01% |
| Zacks Investment Management | 12,940 | $55.1K | 0.00% |
| American Century Companies Inc | 12,756 | $54.3K | 0.00% |
| State of Wyoming | 5,118 | $21.8K | 0.00% |
| Nisa Investment Advisors, LLC | 3,215 | $13.7K | 0.00% |
| Parkside Financial Bank & Trust | 135 | $576 | 0.00% |
| US Bancorp | 30 | $128 | 0.00% |
| Advisor Group Holdings, Inc. | 5 | $21 | 0.00% |
| SWAN Capital LLC | 1 | $4 | 0.00% |
Sold out (29)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.